Differential Effects of a Glucagon-Like Peptide 1 Receptor Agonist in Non-Alcoholic Fatty Liver Disease and in Response to Hepatectomy. - Valdecantos MP; Ruiz L; Pardo V; Castro-Sanchez L; García-Monzón C; Lanzón B; Rupérez J; Barbas C; Naylor J; Trevaskis JL; Grimsby J; Rondinone CM; et al. (Scientific Reports, 2018)